Autoimmune cerebellar ataxia associated with anti-Purkinje cells antibodies: the next frontier of neuroimmunology

• Published in: Annals of translational medicine Vol. 11; no. 7; p. 285
• Main Authors: Zhang, Weihua, Ren, Haitao, Ren, Xiaotun, Fang, Fang, Guan, Hongzhi
• Format: Journal Article
• Language: English
• Published: China AME Publishing Company 15-04-2023
• Subjects: Review; purkinje cell (PC); paraneoplastic cerebellar degeneration (PCD); antibody; Autoimmune cerebellar ataxia (ACA)
• ISSN: 2305-5839; 2305-5839
• DOI: 10.21037/atm-20-2187

Autoimmune cerebellar ataxia (ACA) is an important cause of sporadic cerebellar ataxia. Technological innovation promotes the rapid development of cerebellar autoimmunity researches in recent years. More and more new antibodies have been proposed to be associated with ACA. Several autoantibodies against Purkinje cells (PCs) have been identified, which constitute the main components. These autoantigens are mainly located in the cytoplasm and dendrites of PCs, and exhibit a specific morphology in immunohistochemistry (IHC). Although the clinical features are relatively homogeneous, there were still some differences among different antibodies. Due to the lack of understanding of the disease and the limited detection technology, it is really difficult to diagnose and manage at present. However, unlike the most of hereditary ataxias, ACA is treatable, and even the neurological dysfunction of some patients may be reversible. Therefore, promptly identification, diagnosis and treatment may benefit some patients. Thus, this article elaborates on the clinical manifestations and laboratory characteristics of anti-PCs-antibody-associated ACA in order to help neurologists to understand ACA more comprehensively. At the same time, combining our previous exploratory work as well as the technology available, we try to propose a diagnostic strategy for ACA the text and the relevant differential diagnosis was illustrated in detail.